Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroprotection refers broadly to strategies, mechanisms, and interventions aimed at preserving the structure and function of neurons in the central nervous system (CNS) following injury or during neurodegenerative disease. It is not a discrete molecular target but encompasses multiple biological processes amenable to therapeutic modulation. Research continues into both endogenous protective mechanisms (e.g., Nrf2 pathway) and exogenous agents with potential clinical benefit across various neurological disorders.
Varies depending on the agent used; includes reduction of oxidative stress, inhibition of excitotoxicity, anti-inflammation, regulation of autophagy.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroprotection.